Related references
Note: Only part of the references are listed.Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model
D. Andes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Survival in the presence of antifungals - Genome-wide expression profiling of aspergillus niger in response to sublethal concentrations of caspofungin and fenpropimorph
Vera Meyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Serum differentially alters the antifungal properties of echinocandin drugs
Padmaja Paderu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)
Oliver A. Cornely et al.
CLINICAL INFECTIOUS DISEASES (2007)
High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation
A. Safdar et al.
BONE MARROW TRANSPLANTATION (2007)
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2007)
Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis
Johan Maertens et al.
CANCER (2006)
Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis
David W. Denning et al.
JOURNAL OF INFECTION (2006)
Anidulafungin: A novel echinocandin
Jose A. Vazquez et al.
CLINICAL INFECTIOUS DISEASES (2006)
Caspofungin:: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis
W van Vianen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: Importance of persistence of caspofungin in tissues to understanding drug activity
A Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study
NA Kartsonis et al.
JOURNAL OF INFECTION (2005)
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy
J Maertens et al.
CLINICAL INFECTIOUS DISEASES (2004)
Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: Evidence of concentration-dependent activity
NP Wiederhold et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B
PA Warn et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
In vivo pharmacodynamics of HMR 3270, a glucan synthase inhibitor, in a murine candidiasis model
D Andes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro
JC Bowman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits
V Petraitis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: Pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia
R Petraitiene et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): Reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling
AH Groll et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
